Hervé Girsault

Hervé Girsault is an accomplished executive with extensive experience in the biopharmaceutical and healthcare sectors. Currently serving as Chief Business Officer at BirchBioMed Inc. since March 2023, Girsault is focused on developing novel treatments for organ fibrosis. As Co-founder and Managing Partner of CHG BioVenture SA since 2005, Girsault provides C-Suite advisory services to biotech and medtech companies. Previous roles include Acting Head of Business Development & Licensing at NLS Pharmaceutics AG, President and CEO at Synarc, and Global Head of M&A and Business Development at Novartis. Girsault also held the position of General Manager at Nestlé Nutrition North America (Gerber) and began a career in management consulting with PwC. Girsault earned an MBA in Finance and Corporate Strategy from Columbia Business School.